SynthesisClinical rheumatology2022

Oral methotrexate at doses 15-25 mg/week is non-inferior to parenteral regarding efficacy and safety in the treatment of rheumatoid arthritis: a systematic review and meta-analysis.

Fang Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.